Below are the financial statements of Zealand Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of DKK | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Intangible assets | 12.62a | 12.26a |
| Property, plant and equipment | 46.48a | 47.05a |
| Right-of-use assets | 78.77a | 102.81a |
| Other investments | 0a | 14a |
| Deferred tax assets | 0.99a | 0.93a |
| Trade receivables | 0a | 6.89a |
| Other receivables | 19.41a | 8.91a |
| Marketable securities | 819.63a | 0a |
| Other financial assets | 0a | 7.38a |
| Total non-current assets | 977.9a | 200.21a |
| Inventory | 10.7a | 7.94a |
| Trade receivables | 193.56a | 97.8a |
| Other receivables | 87.21a | 24.56a |
| Corporate tax receivable | 10.23a | 16.44a |
| Other investments | 23.63a | 0a |
| Marketable securities | 7,722.08a | 1,183.75a |
| Cash and cash equivalents | 480.3a | 449.31a |
| Total current assets | 8,527.7a | 1,779.79a |
| Total assets | 9,505.6a | 1,979.99a |
| Share capital | 71.02a | 58.75a |
| Share premium | 14,680.77a | 6,406.23a |
| Currency translation reserve | 22.39a | 22.7a |
| Accumulated losses | -6,157.44a | -4,894.84a |
| Total shareholders' equity | 8,616.74a | 1,592.84a |
| Borrowings | 285.33a | 0a |
| Derivative financial liabilities | 109.67a | 0a |
| Lease liabilities | 90.39a | 102.58a |
| Total non-current liabilities | 485.39a | 102.58a |
| Lease liabilities | 16.04a | 16.66a |
| Trade payables | 254.84a | 125.07a |
| Other payables | 132.59a | 142.85a |
| Total current liabilities | 403.47a | 284.58a |
| Total liabilities | 888.86a | 387.15a |
| Total shareholders' equity and liabilities | 9,505.6a | 1,979.99a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.